Kalpa Retatrutide 10 mg Triple Agonist Research Vial for Labs

It is a lyophilised research vial containing 10 mg of retatrutide, the peptide developed under the code LY3437943. It activates three receptors at once, GIP, GLP-1 and glucagon, which is one more than the dual agonists on the same shelf. The compound has no licensed label anywhere, so the vial is a research material and the trial data quoted here come from investigational protocols.

GIP and GLP-1 activity handle appetite, gastric emptying and glucose dependent insulin release, while the glucagon arm raises energy expenditure, which is the extra mechanism that separates this peptide from the dual agonists. The combined effect is studied as the most potent route in the incretin family. Trial results come from ascending dose groups rather than from a fixed licensed dose.

No human half-life is published in the verified sources, so none is quoted here. Unlike semaglutide, which has an albumin-binding side chain with a measured weekly profile, this peptide has no licensed pharmacokinetic dataset. Any timing used in laboratory work is therefore a design assumption, and comparisons with peptides that do have human data should be made carefully.

Two millilitres of bacteriostatic water give 5 mg per ml, so 2 mg measures 0.4 ml on a U-100 syringe; 1 ml of solvent gives 10 mg per ml and halves that volume. Add the water down the vial wall and do not shake it, then store the solution at 2-8 C without freezing. There is no licensed dose or shelf life to follow, so the vial label is the only guide.

The phase 2 trial reported weight reductions of 8.7, 17.1, 22.8 and 24.2 per cent at 48 weeks across ascending dose groups, and the phase 3 TRIUMPH-1 programme covers 80 weeks in 2339 adults. Those figures describe investigational use under protocol supervision and cannot be transferred to a reconstituted research vial of unverified identity or to unsupervised use.

No. Retatrutide is not on the WADA prohibited list, and the incretin class appears in the monitoring programme, which tracks the substances in samples rather than banning them. That is a lighter position than for growth hormone secretagogues such as ipamorelin, which are prohibited at all times. Athletes should confirm the current list with their federation.

Yes. The 10 mg vial is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.